Literature DB >> 27189915

A Model to Identify Sarcopenia in Patients With Cirrhosis.

Puneeta Tandon1, Gavin Low2, Marina Mourtzakis3, Laura Zenith4, Robert P Myers5, Juan G Abraldes4, Abdel Aziz M Shaheen5, Hina Qamar4, Nadia Mansoor4, Michelle Carbonneau4, Kathleen Ismond4, Sumeer Mann2, Alshimaa Alaboudy4, Mang Ma4.   

Abstract

BACKGROUND & AIMS: The severe depletion of muscle mass at the third lumbar vertebral level (sarcopenia) is a marker of malnutrition and is independently associated with mortality in patients with cirrhosis. Instead of monitoring sarcopenia by cross-sectional imaging, we investigated whether ultrasound-based measurements of peripheral muscle mass, measures of muscle function, along with nutritional factors, are associated with severe loss of muscle mass.
METHODS: We performed a prospective study of 159 outpatients with cirrhosis (56% male; mean age, 58 ± 10 years; mean model for end-stage liver disease score, 10 ± 3; 60% Child-Pugh class A) evaluated at the Cirrhosis Care Clinic at the University of Alberta Hospital from March 2011 through September 2012. Lumbar skeletal muscle indices were determined by computed tomography or magnetic resonance imaging. We collected clinical data and data on patients' body composition, nutrition, and thigh muscle thickness (using ultrasound analysis). We also measured mid-arm muscle circumference, mid-arm circumference, hand grip, body mass index, and serum level of albumin; patients were evaluated using the subjective global assessment scale. Findings from these analyses were compared with those from cross-sectional imaging, for each sex, using logistic regression analysis.
RESULTS: Based on cross-sectional imaging analysis, 43% of patients had sarcopenia (57% of men and 25% of women). Results from the subjective global assessment, serum level of albumin, and most nutritional factors were significantly associated with sarcopenia. We used multivariate analysis to develop a model to identify patients with sarcopenia, and developed a nomogram based on body mass index and thigh muscle thickness for patients of each sex. Our model identified men with sarcopenia with an area under the receiver operating characteristic curve value of 0.78 and women with sarcopenia with an area under the receiver operating characteristic curve value of 0.89.
CONCLUSIONS: In a prospective study of patients with cirrhosis, we found that the combination of body mass index and thigh muscle thickness (measured by ultrasound) can identify male and female patients with sarcopenia almost as well as cross-sectional imaging (area under the receiver operating characteristic curve values of 0.78 and 0.89, respectively). These factors might be used in screening and routine nutritional monitoring of patients with cirrhosis.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CT; Diagnosis; Muscle Wasting; SGA

Mesh:

Year:  2016        PMID: 27189915     DOI: 10.1016/j.cgh.2016.04.040

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  50 in total

1.  A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.

Authors:  Elizabeth J Carey; Jennifer C Lai; Christopher Sonnenday; Elliot B Tapper; Puneeta Tandon; Andres Duarte-Rojo; Michael A Dunn; Cynthia Tsien; Eric R Kallwitz; Vicky Ng; Srinivasan Dasarathy; Matthew Kappus; Mustafa R Bashir; Aldo J Montano-Loza
Journal:  Hepatology       Date:  2019-08-19       Impact factor: 17.425

2.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 3.  Outpatient management of alcohol-related liver disease.

Authors:  Douglas A Simonetto; Vijay H Shah; Patrick S Kamath
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-05

4.  Application of transcutaneous ultrasonography for the diagnosis of muscle mass loss in patients with liver cirrhosis.

Authors:  Kazufumi Kobayashi; Hitoshi Maruyama; Soichiro Kiyono; Sadahisa Ogasawara; Eiichiro Suzuki; Yoshihiko Ooka; Tetsuhiro Chiba; Naoya Kato; Tadashi Yamaguchi
Journal:  J Gastroenterol       Date:  2017-08-18       Impact factor: 7.527

5.  Skeletal Muscle Ultrasound in Critical Care: A Tool in Need of Translation.

Authors:  Marina Mourtzakis; Selina Parry; Bronwen Connolly; Zudin Puthucheary
Journal:  Ann Am Thorac Soc       Date:  2017-10

6.  Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation.

Authors:  David M Chascsa; Jennifer C Lai; Michael A Dunn; Aldo J Montano-Loza; Matthew R Kappus; Srinivasan Dasarathy; Elizabeth J Carey
Journal:  Dig Dis Sci       Date:  2018-09-03       Impact factor: 3.199

Review 7.  Sarcopenia in cirrhosis: A practical overview.

Authors:  Amritpal Dhaliwal; Matthew J Armstrong
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

Review 8.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

Review 9.  Preoperative optimization for major hepatic resection.

Authors:  Sarah Walcott-Sapp; Kevin G Billingsley
Journal:  Langenbecks Arch Surg       Date:  2017-11-18       Impact factor: 3.445

Review 10.  Frailty in Patients With Cirrhosis.

Authors:  Beverley Kok; Puneeta Tandon
Journal:  Curr Treat Options Gastroenterol       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.